Media stories about VWR (NASDAQ:VWR) have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. VWR earned a news sentiment score of 0.18 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 46.6132514235165 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
VWR (NASDAQ:VWR) remained flat at $$33.25 during trading hours on Wednesday. 2,797,900 shares of the stock traded hands, compared to its average volume of 983,321. VWR has a twelve month low of $24.42 and a twelve month high of $37.25. The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.09. The firm has a market cap of $4,380.00 and a P/E ratio of 29.17.
VWR (NASDAQ:VWR) last posted its earnings results on Tuesday, November 7th. The medical research company reported $0.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.08. VWR had a return on equity of 11.79% and a net margin of 4.11%. The company had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.16 billion. During the same quarter last year, the company earned $0.44 earnings per share. The company’s revenue for the quarter was up 5.2% on a year-over-year basis. sell-side analysts expect that VWR will post 1.85 EPS for the current year.
Several research firms have recently commented on VWR. ValuEngine lowered shares of VWR from a “buy” rating to a “hold” rating in a research report on Wednesday, October 11th. BidaskClub cut VWR from a “sell” rating to a “strong sell” rating in a report on Friday, October 13th. Finally, Zacks Investment Research cut VWR from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $34.50.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/31/vwr-vwr-earns-news-sentiment-rating-of-0-18.html.
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR and related companies with MarketBeat.com's FREE daily email newsletter.